Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

NCT05022784 · clinicaltrials.gov ↗

COMPLETED

Status

1798

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Nintedanib

Sponsor

Boehringer Ingelheim